Krystal Biotech Announces First Quarter 2026 Financial and Operating Results

Go back to Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
(NASDAQ: KRYS) Delayed: 339.51 +2.49 (0.74%)
Previous Close $337.02    52 Week High
Open $337.44    52 Week Low
Day High $341.07    P/E N/A 
Day Low $335.72    EPS
Volume 8,943